TERMINATED

Functional Assessment in Liver Transplantation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In order to ensure the equity of the liver allocation process, it is important to create objective, scientifically validated markers of frailty in patients with end-stage liver disease that accurately predict patient outcomes. Many measures have been developed to assess this clinical state in elderly patients, but none have been applied to patients with cirrhosis, a population at increased risk for accelerated functional decline. This protocol is designed to learn more about the effects of functional status (also known as "frailty") in liver transplant patients and patient outcomes both before and after liver transplant.

Official Title

Functional Assessment in Liver Transplantation

Quick Facts

Study Start:2015-10-06
Study Completion:2024-05-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:TERMINATED

Study ID

NCT03870568

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults (≥18 years old)
  2. * Listed for liver transplantation, or are "listable" - i.e, have undergone formal evaluation and been approved for listing if/when patients achieve high enough priority
  3. * Are seen in the outpatient clinic setting
  1. * Have severe hepatic encephalopathy at enrollment (defined by the time to complete the Numbers Connection Test (NCT) \> 120 seconds, which is the first test that the participants complete upon enrollment).

Contacts and Locations

Principal Investigator

James Trotter, MD
PRINCIPAL_INVESTIGATOR
Baylor Health Care System

Study Locations (Sites)

Baylor University Medical Center
Dallas, Texas, 75246
United States

Collaborators and Investigators

Sponsor: Baylor Research Institute

  • James Trotter, MD, PRINCIPAL_INVESTIGATOR, Baylor Health Care System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-10-06
Study Completion Date2024-05-08

Study Record Updates

Study Start Date2015-10-06
Study Completion Date2024-05-08

Terms related to this study

Keywords Provided by Researchers

  • frailty
  • liver transplantation
  • functional status

Additional Relevant MeSH Terms

  • Cirrhosis
  • End Stage Liver Disease